First Genetic Trust, Inc. To Provide IT System To Support Prolonged QT Research At Vanderbilt University Medical Center
10/19/2005 5:12:24 PM
CHICAGO--(BUSINESS WIRE)--Jan. 17, 2005--First Genetic Trust, Inc., (FGT) and the Vanderbilt University Medical Center (VUMC) announced today that FGT will provide its web-based enTRUST(R) Study Management system to expand VUMC's studies of the genetics of drug-induced Prolonged QT, a side-effect for many different classes of drugs. Patients who exhibit Prolonged QT may develop heart arrhythmias that can lead to sudden death in some cases.
comments powered by